BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News
Gland Pharma Ltd Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
543245
ISIN Demat
INE068V01023
Book Value (Rs)
655.2871714
NSE Symbol
GLAND
Divident Yield %
0.71
Market Cap
(Rs In Cr.)
46,220
P/E (TTM)
32.72
EPS (TTM)
85.62
Face Value
(Rs)
1
Date Heading
14-Aug-26 Gland Pharma appoints Deepak Sapra as CEO
11-Aug-26 Volumes soar at Gland Pharma Ltd counter
10-Aug-26 Benchmarks trade in positive terrain; realty shares jump
10-Aug-26 Gland Pharma rises after signing strategic CDMO pact with global pharm
10-Aug-26 Gland Pharma consolidated net profit rises 47.09% in the June 2026 qua
05-Aug-26 Gland and Neuland Lab announces long term strategic CDMO partnership
29-Jul-26 Gland Pharma gains after USFDA approves generic Sugammadex Injection
29-Jul-26 Gland Pharma receives USFDA approval for Sugammadex Injection
25-Jul-26 Gland Pharma to convene board meeting
07-Jul-26 Gland Pharma Ltd gains for third straight session
16-Jun-26 Gland Pharma director resigns
02-Jun-26 Gland Pharma allots 2.03 lakh equity shares under ESOS
18-May-26 Nifty trades below 23,400 level; consumer durables shares tumble
18-May-26 Volumes spurt at J K Cements Ltd counter
18-May-26 Gland Pharma spurts as Q4 PAT jumps 97% YoY to Rs 367 crore
Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)